Parkinson’s Disease Therapeutics Market Research Report by Type, by Drug Class, by Distribution Channel, by End Use - Global Forecast to 2025 - Cumulative Impact of COVID-19

Parkinson’s Disease Therapeutics Market Research Report by Type, by Drug Class, by Distribution Channel, by End Use - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • August 2020 •
  • 175 pages •
  • Report ID: 5941566 •
  • Format: PDF
Parkinson’s Disease Therapeutics Market Research Report by Type (Intestinal Infusion, Oral, Subcutaneous, and Transdermal), by Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor, Dopamine Receptor Agonist, and MAO Inhibitor), by Distribution Channel, by End Use - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global Parkinson’s Disease Therapeutics Market is expected to grow from USD 4,985.67 Million in 2019 to USD 7,522.33 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.09%.

Market Segmentation & Coverage:
This research report categorizes the Parkinson’s Disease Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Intestinal Infusion is projected to witness the highest growth during the forecast period"

Based on Type, the Parkinson’s Disease Therapeutics Market studied across Intestinal Infusion, Oral, Subcutaneous, and Transdermal. The Oral commanded the largest size in the Parkinson’s Disease Therapeutics Market in 2019. On the other hand, the Intestinal Infusion is expected to grow at the fastest CAGR during the forecast period.

"The Anticholinergic is projected to witness the highest growth during the forecast period"

Based on Drug Class, the Parkinson’s Disease Therapeutics Market studied across Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor, Dopamine Receptor Agonist, and MAO Inhibitor. The Carbidopa/Levodopa commanded the largest size in the Parkinson’s Disease Therapeutics Market in 2019. On the other hand, the Anticholinergic is expected to grow at the fastest CAGR during the forecast period.

"The Online Pharmacy is projected to witness the highest growth during the forecast period"

Based on Distribution Channel, the Parkinson’s Disease Therapeutics Market studied across Hospital Pharmacy, Online Pharmacy, and Retailer Pharmacy. The Hospital Pharmacy commanded the largest size in the Parkinson’s Disease Therapeutics Market in 2019. On the other hand, the Online Pharmacy is expected to grow at the fastest CAGR during the forecast period.

"The Clinic is projected to witness the highest growth during the forecast period"

Based on End Use, the Parkinson’s Disease Therapeutics Market studied across Clinic and Hospital. The Hospital commanded the largest size in the Parkinson’s Disease Therapeutics Market in 2019. On the other hand, the Clinic is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Parkinson’s Disease Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Parkinson’s Disease Therapeutics Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Parkinson’s Disease Therapeutics Market including Abbvie, Inc., ACADIA Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., Apotex, Inc., Bausch Health Companies, Inc., Boehringer Ingelheim International GmbH, Cipla, Inc., Daiichi Sankyo Company, H. Lundbeck A/S, Mylan N.V., Novartis AG, Orion Corporation, Par Pharmaceutical by Endo International PLC, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., UCB S.A., and WOCKHARDT.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Parkinson’s Disease Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Parkinson’s Disease Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Parkinson’s Disease Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Parkinson’s Disease Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Parkinson’s Disease Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Parkinson’s Disease Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Parkinson’s Disease Therapeutics Market?